Clinical Trial Update: Phase 3 Study of KP-100LI in Subjects With Vocal Fold Scar [Phase 3]

View source ↗

Summary

Kringle Pharma is conducting a Phase 3 trial of KP-100LI for vocal fold scar. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vocal Fold Scar

Drugs mentioned

• KP-100LI

Snippet

Sponsor: Kringle Pharma, Inc. | Conditions: Vocal Fold Scar | Phase 3 | Status: RECRUITING